Irritable Bowel Syndrome (IBS)
IRRITABLE BOWEL SYNDROME (IBS)
Feature Article
AGA Recommendations for Evaluation of Functional Diarrhea and Diarrhea-Predominant IBS in Adults
Based on technical review and expert consensus, a guideline committee put together by the American Gastroenterological Association (AGA) released official recommendations on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome (IBS-D) in immunocompetent adults. This report was published in Gastroenterology. Members of the AGA guideline committee and authors of the technical review…
Latest News
Multidisciplinary Care Improves Symptoms Best in Functional GI Disorders
Researchers compared integrated multidisciplinary clinical care vs gastroenterologist-only care with regard to symptoms, specific functional disorders, psychological state, quality of life, and cost of care for treating functional gastrointestinal disorders.
Prevalence of Adverse Pregnancy Outcomes Assessed With Biologics for IBD
The study aimed to determine the prevalence of adverse pregnancy outcomes associated with biologic use in women with IBD.
Poor Diagnostic Power of FBD With Colonoscopy
Investigators examined the diagnostic yield of colonoscopies for patients with functional bowel disorders without alarm features.
Malignancy Risk Low After Treating Long-Term With Tofacitinib for UC
Researchers assessed malignancy frequency in the tofacitinib ulcerative colitis clinical development program, along with frequency of malignancy events and rates.
Gut Microbiota Alterations Observed With Personalized IBS Treatment
Treatments guided by metagenomics may result in symptom improvement for patients with irritable bowel syndrome.
Acupuncture Possibly an Effective Therapy for Irritable Bowel Syndrome Symptoms
Use of acupuncture reduced total irritable bowel syndrome-Symptom Severity Score to a greater extent than use of other pharmacologic therapies.
Guideline Issued on the Use of Probiotics for Managing GI Disorders
Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.
IBS Frequency Higher in Patients With Acne
A novel study examines the relationship between acne vulgaris and irritable bowel syndrome.
Cannabis Use Associated with Fewer Hospital Readmissions in Patients with IBS
Lower total hospitalization costs were identified in patients with IBS who used cannabis compared with patients who did not use cannabis.
Non-viable, Heat-inactivated Bifidobacterium bifidum MIMBb75 Improves IBS Symptoms
Use of a heat-inactivated form of a probiotic was associated with significant reduction in abdominal pain as well as relief of symptoms in patients with irritable bowel syndrome.
Mindfulness-Based Stress Reduction May Cut IBS Symptoms
Mindfulness-based stress reduction training is associated with robust improvements in gastrointestinal symptoms for patients with irritable bowel syndrome.
Next-Gen Rechargeable Neurostimulator Implant Approved for Urinary, Bowel Dysfunction
The FDA has approved a new version of Axonics Modulation’s rechargeable implantable sacral neurostimulator (r-SNM) system that allows patients to decrease the frequency of charging to once a month.
Dead' Probiotic Treatment May Help Reduce Irritable Bowel Symptoms
Probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome.
New Data on Peppermint Oil and Irritable Bowel Syndrome
A commonly used over-the-counter treatment for IBS is peppermint oil. The exact mechanism of action in IBS is not entirely known; however, it has been postulated that it may be mediated through smooth muscle relaxation, antimicrobial effects, modulation of pain receptors, and 5-hydroxytryptamine antagonism.
Tenapanor Demonstrates Efficacy, Tolerability, and Safety in Treating IBS-C
Tenapanor 50 mg has demonstrated efficacy, tolerability, and safety in treating constipation-predominant irritable bowel syndrome.
Challenges, Controversies in Drug Safety Monitoring
The FDA plays a critical role in the evaluation of drug safety prior to approval and following introduction into clinical practice.
No Distinct Microbiome Profile for IBS in Swedish Population
The researchers concluded that this is the first study to investigate the mucosa-associated gut microbiome in an adult population-based cohort and that no distinct microbial signature was observed in IBS.
Effects of Human Milk Oligosaccharides on Gastrointestinal Symptoms in IBS: Q&A With Dr Magnus Simrén
Oral supplementation with 2 unique forms of human milk oligosaccharides can provide nutritional support that significantly reduces abnormal stool consistency, abdominal pain, and bloating and improves health-related quality of life in patients with IBS of all subtypes.
Zinc Deficiency May Perpetuate Irritable Bowel Syndrome Pathology/Symptoms
Zinc deficiency may perpetuate the underlying pathophysiology of IBS as well as associated psychiatric conditions, via the role zinc plays in the “brain-gut” axis, the immune system, and gastrointestinal barrier integrity.
Rifaximin and Meaningful Pain Improvement in IBS With Diarrhea
Rifaximin treatment resulted in meaningful pain improvements of abdominal pain in a high percentage of patients, irrespective of baseline severity category and treatment course.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Irritable Bowel Syndrome (IBS)
